Orgenesis Inc (ORGS)

[jfk]

Q2 Catalyst in: $11M qtr. Good sales rate. Very high burn, and CEO just took down a $3.6MILLION BONUS. Unconscionable! Stock will come down from $5+ level as the likelihood of a capital raise is now looming by year end. Cash management here becomes a very large issue. Bad, Bad Optics!!

[jfk]

Big buy <$4. Hope it gets there. Any day with the right catalyst it shoots back to $6. Where are the catalysts?

[jfk]

On sale at $4.19. Going to the $3's, obviously. Question is whether this goes back near the 3 year lows of $2.80's. It is being torched right now. Will be a strong buy under $3.50.

[crudeoil24]

Fabulous news! buy the dips; there is a SEC filing 424B5 from a month ago. The shelf placement shoud be near completion. In near future seeing all time new highs.
Get any shares under 5.00 if you are interested.

[Eagle1]

Hello Crude and Smart money. ORGS. Whats up here?

Thank You

[crudeoil24]

Biggest volume day ever: ORGS > Orgenesis Q1 EPS $0.01 Up From $(0.39) YoY, Sales $9.39M Up From $1.88M YoY
7:11 am ET May 7, 2021 (Benzinga) Print
Orgenesis (NASDAQ:ORGS) reported quarterly earnings of $0.01 per share. This is a 102.56 percent increase over losses of $(0.39) per share from the same period last year. The company reported $9.39 million in sales this quarter. This is a 399.95 percent increase over sales of $1.88 million the same period last year.

[XWAVXALMIMAN]

Thanks iHub for changing name

Organic Solutions is gone. Maybe we can get Orgenesis moving - good start today. I sold a little ATHX and bought more ORGS. I STILL LOVE ATHX, PSTI, RDHL, MRNA

[XWAVXALMIMAN]

ORGS & ATHX both in Russel 3000, 2000 and Microcap

https://content.ftserussell.com/sites/default/files/rmicro_membershiplist_20200629.pdf

[TheFinalCD]

News Alert: Orgenesis Added to Russell 3000® Index

ORGS

[XWAVXALMIMAN]

RDHL had good news today. See my post there and other news posted in iHub

[doogdilinger]

Nice congratz buddy, so many hotties out there these days it's insane! So best of cont'd success here and everywhere else cheers!

[XWAVXALMIMAN]

Doogie, good luck to us..I did sell 2,000 shares of PSTI at 7.65 and got 2,000 more ORGS at 6.82-7.03. They kept raising the price and had some left over for RDHL. if ORGS gets above PSTI. I’ll sell trade back. As long as they keep playing leap frog I’ll go back and forth. It’s great to have zero commission. CAPR had a good day. I considered getting back in.

[doogdilinger]

lol gotta luv a hot market right buddy! Enjoy your eve cheers!

[PEACHMAN]

dang your everywhere Boss!

[doogdilinger]

Awesome nice to meet you XWAV!

[XWAVXALMIMAN]

Me too. I had 5,000 shares before. I couldn’t resist buying more PSTI at 7.05-7.10 when ORGS was 7.77 (lucky #). I was able to trade one for the other and used the difference to buy ATHX. I still like Pluristem better but like ORGS and like being diversified. Got 2,000 shares back today. Would love to get more.

[doogdilinger]

Started accumulating today! Talk further soon folks! Enjoy your eve:)

[PEACHMAN]

ORGS is a buy and hold for me

[XWAVXALMIMAN]

Orgenesis added to Russell Index

https://content.ftserussell.com/sites/default/files/ru3000_additions_20200605.pdf

[PEACHMAN]

THE key is buying ORGS before pps takes off.

[XWAVXALMIMAN]

Why does this board say Organic Solutions instead of Orgenesis? No posts since 5/11.
News looks good and $10 million stock buyback started today

https://www.globenewswire.com/news-release/2020/05/11/2030989/0/en/Orgenesis-First-Quarter-2020-Revenue-Increases-348-to-1-9-Million-Reflecting-Success-of-CGT-Biotech-Platform.html

https://www.globenewswire.com/news-release/2020/05/15/2034158/0/en/Orgenesis-Announces-Stock-Repurchase-Plan-of-Up-to-10-Million.html

[PEACHMAN]

Nice news today on ORGS

[Hikiro]

Weird it webt down

[stocktrademan]

ORGS buy 6.91























normal chart




log chart

[TenKay]

ORGS Uplisted to Nasdaq

http://otce.finra.org/DLDeletions

[stocktrademan]

When are they uplisting to NASDAQ?

I don't know maybe google knows. It isn't something I look at to decide what to trade.

[conix]

When are they uplisting to NASDAQ?

[stocktrademan]

It's fine good enough for me to get in now and not worry about it. The upswing is going to be definitely more than this drawdown. That's what matters.

[conix]

Maybe buy a little lower than 9.50.

[stocktrademan]

ORGS buy 9.50

ascending triangle breakout on the PPO signal
high volume on advances and low volume on retracements bullish
breakout over the ichimoku cloud
inverted head and shoulders bottom



















normal chart




log chart

[TrendTrade2016]

loaded ORGS this monster is about to turn heads!!!

[Renee]

ORGS one for 12 reverse split: (PPS closed today at .25)

http://otce.finra.org/DLSymbolNameChanges

[Brando1975]

Article from Seeking Alpha about Orgs.

When You're Knocked Off The Horse…Get Back On! The Mantra Of A Biotech Investor…A Look Back On The Last 12 Months

Oct. 18, 2017 1:36 AM

When You're Knocked Off the Horse! Get Back On!

The Mantra of a Biotech Investor...A Look Back on the Last 12 Months

10-18-2017

I realize it's been nearly six months since my last update. My absence has not been due to lack of activity in my biotech picks.  It's been 1 year since my first "Knocked Off the Horse" article. I'm taking the one-year anniversary as an   opportunity to see how the last year treated my stable.  The performance of a couple of my thoroughbreds had me cashing in at the ticket window and a couple of nags needed to be sent out to pasture.  I'll provide a brief update on the last few months and do my best at looking forward.

ORGS, Orgenesis - added 2.28.17, pps on 2.28 was $.80, pps October 2017 - $.42.  I added Orgenesis to my under followed category but the jockey continues to change, I'm actually not even sure it has a jockey.  I've now added ORGS to the glue factory category.  I'll take another look again if they ever get management figured out.  Taking all proceeds and adding to PKTX.

ACXA, Accurexa, added to the not followed list on 4.02.2017 when the stock was at $.18.  Last trade on 10.17.2017 was just over .09.  I'm sending this one out to pasture as well.  The science is intriguing but the cap table is a mess and the ownership/management structure is a convoluted mess. Proceeds from this go to PKTX as well.

 



PKTX, ProtoKinetix - October 2016 pps - .07, October 2017 pps - .07. Don't be fooled by the price being the same in now as it was in October 2016. This company has made far greater strides than what I had even imagined.  The company began its first human trials this year and the stock got as high as $.15 on the news.  I would anticipate data from these trials to begin coming out early in 2018.  The trials that are currently underway are for Diabetes, that in and of itself is enough for me to own the stock,  but the company put press out on 10.17.2017 and informed us that they will also be using their molecule for Kidney Ischemia, Normothermic Liver Perfusion, Retinal Cell Replacement and Monocional antibody production.  This company is no one trick pony!  The stock doesn't get the attention it should, this is in large part due to the fact it is trading at $.07, many biotech investors don't take a penny stock too seriously.  A little due diligence shows that this company was resurrected from the dead by current management and now has an entirely clean cap table with no debt whatsoever and as evidenced by the recent press, they're really getting things done.  It's not often I get this fired up about a penny stock biotech, but PKTX is a penny stock in price only.  The cap table and technology are deserving of a market cap far greater than what the market is currently giving it.  Once they begin to release study data the market will realize this is Secretariat and not some also ran. I'm loading up on this one while she's still priced like a longshot.

[wiltonio]

Theodorus Ii Sa has filed a new activist 13D, reporting 8.92% ownership in $ORGS - https://fintel.io/i/theodorus-ii and https://fintel.io/i/theodorus-ii

[wiltonio]

Belenger Olivier has filed a new activist 13D, reporting 13.05% ownership in $ORGS - https://fintel.io/soh/us/orgs/belenger-olivier and https://fintel.io/i/belenger-olivier

[stocktrademan]

ORGS bullish 0.85

$.85 NOW. Outlook on this one???

As long as the MACD is above 0 it should continue to go higher.

So if lately it completed a bull flag the rise was around +0.60 before.

I would add that to the current price to get 1.45 as a reasonable outlook for a peak or pause. It might also consolidate around 1.1 on the way.

That doesn't mean it stops making higher highs and higher lows as the while the MACD is above 0. It just makes note of a highly probable peak nearby on the way...where it stops nobody knows really.












normal chart




log chart

[IPO$]

NOTE 1 – DESCRIPTION OF BUSINESS
a.
General
Orgenesis Inc. (the “Company”) was incorporated in the state of Nevada on June 5, 2008, under the name Business Outsourcing Services, Inc. Effective August 31, 2011, the Company completed a merger with its subsidiary, Orgenesis Inc., a Nevada corporation which was incorporated solely to effect a change in its name. As a result, the Company changed its name from “Business Outsourcing Services, Inc.” to “Orgenesis Inc.” The consolidated financial statements include the accounts of Orgenesis Inc., its wholly-owned subsidiaries MaSTherCell S.A (the “MaSTherCell”), its Belgian based subsidiary and a contract development manufacturing organization, or CDMO (see also note 3), specialized in cell therapy development for advanced medicinal products; Orgenesis SPRL (the “Belgian Subsidiary”), a Belgian based subsidiary which is engaged in development and manufacturing activities together with clinical development studies in Europe, and later on to be the Company’s center for activities in Europe; Orgenesis Maryland Inc. (the “U.S. Subsidiary”) a Maryland corporation, and Orgenesis Ltd. an Israeli corporation.
The Company is a regenerative therapy company with expertise and experience in cell therapy development and manufacturing.
The Company’s cell therapy technology derives from published work of Prof. Sarah Ferber, our Chief Science Officer and a researcher at Tel Hashomer Medical Research (“THM”), a leading medical hospital and research center in Israel, who established a proof of concept that demonstrates the capacity to induce a shift in the developmental fate of cells from the liver and transdifferentiating (converting) them into “pancreatic beta cell-like” insulin-producing cells. Its development activities with respect to cell-derived and related therapies, which are conducted through Orgenesis Ltd. (the “Israeli Subsidiary”), have, to date, been limited to laboratory and preclinical testing.

[IPO$]

$.85 NOW. Outlook on this one???

[stocktrademan]

ORGS bullish 0.3800

[Joeyohso]

I liked it during all the healthcare conferences but it didnt move much so i dumped it. Havent looked back until just now. Looks like its moving

[authoredone]

I'm looking at this and wonder if you still feel like this could move up. I know jan has passed, but that doesn't mean you weren't wrong.

[Joeyohso]

this reminds me of IBIO and that went from .40 to $4

[Joeyohso]

This is going to be big in January. All diabetes stocks, I know tobin smith was paid $50k to push this. He gave a price target of $2.50, I'm loading any dips. May be a gamble but I have enough DD to reduce my risk.

[stocktrademan]

$ORGS DD Notes ~ http://www.ddnotesmaker.com/ORGS

bullish

$ORGS recent news/filings

## source: finance.yahoo.com

Mon, 25 Aug 2014 10:00:37 GMT ~ ORGENESIS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Offic


read full: http://biz.yahoo.com/e/140825/orgs8-k.html
*********************************************************

Thu, 07 Aug 2014 10:01:52 GMT ~ ORGENESIS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Offic


read full: http://biz.yahoo.com/e/140807/orgs8-k.html
*********************************************************

Tue, 05 Aug 2014 17:42:36 GMT ~ ORGENESIS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities


read full: http://biz.yahoo.com/e/140805/orgs8-k.html
*********************************************************

Mon, 04 Aug 2014 13:00:00 GMT ~ Scott Carmer Named as CEO of Orgenesis North America

[Marketwired] - Orgenesis Inc. , a leader in the emerging fields of cellular therapy and re-generative medicine, today announced the appointment of industry veteran Scott Carmer as CEO of the company's North American ...

read full: http://finance.yahoo.com/news/scott-carmer-named-ceo-orgenesis-130000087.html
*********************************************************

Wed, 16 Jul 2014 17:04:08 GMT ~ ORGENESIS INC. Financials


read full: http://finance.yahoo.com/q/is?s=orgs
*********************************************************


$ORGS charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com


$ORGS company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/ORGS/company-info
Ticker: $ORGS
OTC Market Place: OTCQB
CIK code: 0001460602
Company name: Orgenesis, Inc.
Company website: http://www.orgenesis.com
Incorporated In: NV, USA

Business Description: Orgenesis (ORGS) is a development stage company with a novel therapeutic technology that employs a molecular and cellular approach directed at converting a patient's own liver cells into functional insulin producing cells, as a treatment for diabetes. The Company believes that converting the diabetic patient's own tissue into insulin-producing cells overcomes the problem of donor shortage and removes the risk of transplant rejection. If successful, this could mean the end of diabetes, as we now know it. For more information visit: www.orgenesis.com.Less >>


$ORGS share structure

## source: otcmarkets.com

Market Value: $45,531,395 a/o Aug 26, 2014
Shares Outstanding: 54,791,089 a/o Jul 09, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$ORGS extra dd links

Company name: Orgenesis, Inc.
Company website: http://www.orgenesis.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ORGS+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ORGS+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ORGS+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ORGS/news - http://finance.yahoo.com/q/h?s=ORGS+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ORGS/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ORGS/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ORGS+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ORGS
DTCC (dtcc.com): http://search2.dtcc.com/?q=Orgenesis%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Orgenesis%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Orgenesis%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.orgenesis.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.orgenesis.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.orgenesis.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ORGS
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001460602&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ORGS/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ORGS/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ORGS&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ORGS
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ORGS/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ORGS+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ORGS+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ORGS
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ORGS
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ORGS+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ORGS/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ORGS+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ORGS.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ORGS
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ORGS/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ORGS/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ORGS
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ORGS
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ORGS:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ORGS
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ORGS



$ORGS DD Notes ~ http://www.ddnotesmaker.com/ORGS

[Tommy]

$ORGS - chart update

[Tommy]

Chart Update

[Tommy]

$ORGS - Technology Development

http://www.orgenesis.com/technology/development

[Tommy]

Diabetes Opportunity

http://www.orgenesis.com/market/our-opportunity

[Tommy]

$ORGS - Orgenesis Meets With The Paul-Ehrlich Institute

http://finance.yahoo.com/news/orgenesis-meets-paul-ehrlich-institute-130000943.html

... "This meeting was part of a parallel scientific advisory process that we are engaging in with the U.S. Food and Drug Administration and the EMA as we plan for the first in-human clinical trials of our diabetes treatment product candidate,” said Jacob BenArie, CEO of Orgenesis. “We are pleased with the positive reception that we have received to date and look forward to continued dialogue with the senior regulatory bodies.” ...

[Cobra Kai]

There it is back to $1.00